# Association between lactate-to-albumin ratio and shortand long-term mortality in critically ill patients with ischemic stroke: A retrospective analysis of the MIMIC-IV database

**Authors:** Sisi Qin, Jijie Xiao, Shiqi Yuan, Huitao Zhang, Yang Liu, Ningjun Li, Songjin He, Li Kou

PMC · DOI: 10.5937/jomb0-54979 · Journal of Medical Biochemistry · 2025-06-13

## TL;DR

This study shows that a blood marker called lactate-to-albumin ratio (LAR) can predict survival chances in ICU patients with ischemic stroke, both in the short and long term.

## Contribution

The study identifies LAR as a novel independent predictor of mortality in critically ill ischemic stroke patients using the MIMIC-IV database.

## Key findings

- Higher LAR levels were associated with increased ICU, hospital, 30-day, and 90-day mortality rates in ischemic stroke patients.
- Multivariable analysis confirmed LAR as an independent predictor of 30- and 90-day mortality.
- Non-linear associations were found between LAR and hospital, 30-day, and 90-day mortality outcomes.

## Abstract

Stroke is a major cause of disability and cognitive deficits, with ischemic stroke (IS) being the most prevalent type, especially in critically ill patients in intensive care units (ICUs). The lactate-to-albumin ratio (LAR) has emerged as a potential predictor of disease outcomes, but its association with shortand long-term mortality in critically ill IS patients is unclear.

This study analyzed data from 894 critically ill IS patients from the MIMIC-IV database, categorized into LAR tertiles. Clinical endpoints included ICU, hospital, and 30and 90-day all-cause mortality. Survival differences were assessed using Kaplan-Meier analysis. Cox proportional-hazards regression models and restricted cubic spline (RCS) analysis evaluated the association between LAR and mortality outcomes. Subgroup analyses examined the modifying effects of clinical characteristics on LAR's predictive value.

The ICU, hospital, 30-, and 90-day mortality rates were 15.0%, 22.3%, 28.2%, and 36.1%, respectively. Higher LAR levels were associated with reduced survival times and increased mortality risks in all endpoints. Multivariable Cox models confirmed LAR as an independent predictor of 30and 90-day mortality. RCS analysis indicated a linear relationship between LAR and ICU mortality (P = 0.109), and a non-linear association with hospital (P = 0.005), 30-day (P < 0.001), and 90-day mortality (P < 0.001). Subgroup analyses highlighted significant interactions for respiratory failure and GCS.

LAR is a robust predictor of shortand longterm mortality in critically ill IS patients, offering clinicians a valuable tool for risk stratification and decision-making.

## Linked entities

- **Diseases:** ischemic stroke (MONDO:1060198)

## Full-text entities

- **Genes:** ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}
- **Diseases:** Stroke (MESH:D020521), cognitive deficits (MESH:D003072), critically ill (MESH:D016638), disability (MESH:D009069), respiratory failure (MESH:D012131), IS (MESH:D002544)
- **Chemicals:** lactate (MESH:D019344)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12357638/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12357638/full.md

## References

49 references — full list in the complete paper: https://tomesphere.com/paper/PMC12357638/full.md

---
Source: https://tomesphere.com/paper/PMC12357638